GlassScriptPhysician profile
Bret Theodore Sobota
NPI 1518051036
$1,023.64
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $411 · 2022: $157 · 2023: $28.37 · 2024: $16.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $193.04 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $179.10 | 2019-2020 | |
| Stryker Corporation | $145.34 | 2019 | |
| Cochlear Americas | $129.73 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $85.81 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.07 | 2020-2022 | |
| Smith+Nephew, INC. | $45.69 | 2020 | |
| Aerin Medical INC. | $37.60 | 2019-2024 | |
| Acclarent, INC | $36.88 | 2019 | |
| Genzyme Corporation | $34.95 | 2019-2020 | |
| Integra Lifesciences Corporation | $28.37 | 2023 | Integra, Integra Duo, Microfrance |
| Ambu INC. | $24.28 | 2020-2022 | |
| Lilly USA, LLC | $16.88 | 2020 | |
| Karl Storz Endoscopy-America | $15.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Sobota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.